Nicotinamide riboside chloride
CAS 23111-00-4
Nicotinamide riboside chloride (CAS 23111-00-4) is a pharmaceutical compound with 0 bioactivity targets and 26 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Nicotinamide riboside chloride is linked to DTXSID001355428 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Nicotinamide riboside chloride used for in pharmaceutical contexts?
Nicotinamide riboside chloride (CAS 23111-00-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Nicotinamide riboside chloride?
Nicotinamide riboside chloride has 26 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Asthenia, Catheterisation cardiac, Cough, Drug intolerance, Dysphonia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Nicotinamide riboside chloride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for NIACINAMIDE RIBOSIDE CHLORIDE with EU status "permitted".
What clinical phase is Nicotinamide riboside chloride in?
No phase 1-4 clinical development badge is rendered for Nicotinamide riboside chloride because the matched compound identifier rows do not contain a max-phase value.